Cardiovascular dysfunction associated with tyrosine kinase inhibitor use in patients with metastatic thyroid cancer

27 May 2019 (17:48 - 17:54)
Organised by:
Congress Presentation Part of: Rapid Fire 6 - Risk stratification and prognosis Cardio-Oncology HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by